87 related articles for article (PubMed ID: 2898272)
1. Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats.
Płaźnik A; Tamborska E; Hauptmann M; Bidziński A; Kostowski W
Brain Res; 1988 Apr; 447(1):122-32. PubMed ID: 2898272
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants reduce inactivity during both inescapable shock administration and shuttle-box testing.
Murua VS; Molina VA
Eur J Pharmacol; 1991 Nov; 204(2):187-92. PubMed ID: 1806386
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test.
Mancinelli A; Borsini F; d'Aranno V; Lecci A; Meli A
Eur J Pharmacol; 1988 Dec; 158(3):199-205. PubMed ID: 3253098
[TBL] [Abstract][Full Text] [Related]
4. Adinazolam both prevents and reverses the long-term reduction of daily activity produced by inescapable shock.
Maier SF; Silbert LH; Woodmansee WW; Desan PH
Pharmacol Biochem Behav; 1990 Aug; 36(4):767-73. PubMed ID: 2217504
[TBL] [Abstract][Full Text] [Related]
5. The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats.
Soubrie P; Martin P; el Mestikawy S; Thiebot MH; Simon P; Hamon M
Pharmacol Biochem Behav; 1986 Jul; 25(1):1-6. PubMed ID: 3749215
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs.
Lacerra C; Martijena ID; Bustos SG; Molina VA
Brain Res; 1999 Feb; 819(1-2):40-7. PubMed ID: 10082859
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical and behavioral consequences of mild, uncontrollable shock: effects of PCPA.
Edwards E; Johnson J; Anderson D; Turano P; Henn FA
Pharmacol Biochem Behav; 1986 Aug; 25(2):415-21. PubMed ID: 2945212
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
Heffner TG; Seiden LS
Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
[TBL] [Abstract][Full Text] [Related]
10. Delayed behavioral response to antidepressant drugs following selective damage to the hippocampal noradrenergic innervation in rats.
Soubrie P; Martin P; el Mestikawy S; Hamon M
Brain Res; 1987 Dec; 437(2):323-31. PubMed ID: 3124930
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.
Rampersaud N; Harkavyi A; Giordano G; Lever R; Whitton J; Whitton PS
Neuropeptides; 2012 Oct; 46(5):183-93. PubMed ID: 22921965
[TBL] [Abstract][Full Text] [Related]
12. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock.
Shanks N; Anisman H
Psychopharmacology (Berl); 1989; 99(1):122-8. PubMed ID: 2506597
[TBL] [Abstract][Full Text] [Related]
13. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
Kleinrok Z; Wielosz M
Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
[TBL] [Abstract][Full Text] [Related]
14. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test.
West CH; Weiss JM
Psychopharmacology (Berl); 2005 Oct; 182(1):9-23. PubMed ID: 16047194
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant-like effect of ethynyl estradiol is mediated by both serotonergic and noradrenergic systems in the forced swimming test.
Vega-Rivera NM; López-Rubalcava C; Estrada-Camarena E
Neuroscience; 2013 Oct; 250():102-11. PubMed ID: 23845746
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic influences on escape deficits produced by uncontrollable stress.
Anisman H; Glazier SJ; Sklar LS
Psychopharmacology (Berl); 1981; 74(1):81-7. PubMed ID: 6791211
[TBL] [Abstract][Full Text] [Related]
17. Aldrin-induced locomotor activity: possible involvement of the central GABAergic-cholinergic-dopaminergic interaction.
Jamaluddin S; Poddar MK
Pol J Pharmacol; 2001; 53(1):21-30. PubMed ID: 11785907
[TBL] [Abstract][Full Text] [Related]
18. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).
Siuciak JA; Lewis DR; Wiegand SJ; Lindsay RM
Pharmacol Biochem Behav; 1997 Jan; 56(1):131-7. PubMed ID: 8981620
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
Sawynok J; Reid A
J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
